CHU Marseille - Hôpital la Timone

corporate_fareorganization

CHU Marseille - Hôpital la Timone

- Funding / Projects
  (79)

79 Projects, page 1 of 16

Cancer du sein triple négatif : incidence des mutations des gênes BRCA1/2, PALB2, P53, Corrélation aux profils moléculaires et implications pronostiques Breast cancer: incidence of BRCA1/BRCA2 Mutations, correlation to moleculares profils and pronostic implications
assignment_turned_inProjectPartners:Institut Sainte Catherine, Institut Sainte Catherine, NOP, Centre Jean Perrin, Centre Antoine Lacassagne +5 partners
Institut Sainte Catherine,
Institut Sainte Catherine,
NOP,
Centre Jean Perrin,
Centre Antoine Lacassagne,
Institut Paoli-Calmettes- (IPC),
CHU Marseille - Hôpital la Timone,
CHU Marseille - Hôpital la Timone,
Ausl 4 Piazza Ospedale,
NOP
Funder: Institut National du Cancer Project Code: INCa-DGOS-2596
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
Intérêt de la Tomographie par Emission de Positons au 18-fluorodeoxyglucose dans le dépistage du cancer chez les patients atteints de maladie veineuse thrombo-embolique idiopathique36.
assignment_turned_inProjectPartners:Centre Hospitalier Universitaire de Brest, Centre Hospitalier Universitaire de Saint-Étienne, ORGANISME NON ASSOCIE, CHU Marseille - Hôpital la Timone, Hôpital Morvan +3 partners
Centre Hospitalier Universitaire de Brest,
Centre Hospitalier Universitaire de Saint-Étienne,
ORGANISME NON ASSOCIE,
CHU Marseille - Hôpital la Timone,
Hôpital Morvan,
CHU Marseille - Hôpital la Timone,
CHU,
Centre Hospitalier Universitaire de Brest
Funder: Institut National du Cancer Project Code: INCa-DGOS-348
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
Étude prospective randomisée multicentrique comparant les résultats de la greffe d’une versus deux unités de sang placentaire chez des patients âgés de moins de 35 ans atteints de leucémie aiguë en rémission.
assignment_turned_inProjectPartners:CHU Marseille - Hôpital la Timone, CHU Marseille - Hôpital la Timone
CHU Marseille - Hôpital la Timone,
CHU Marseille - Hôpital la Timone
Funder: Institut National du Cancer Project Code: INCa-DGOS-1249
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
Title of the study – First International Randomized Study in MAlignant Progressive Pheochromocytoma and Paraganglioma (PPGL)- FIRST MAPPP
assignment_turned_inProjectPartners:Hôpital Larrey -CHU Toulouse, Institut Gustave Roussy, Hôpital Larrey -CHU Toulouse, Centre Léon Bérard, Hôpital Haut-Lévêque +6 partners
Hôpital Larrey -CHU Toulouse,
Institut Gustave Roussy,
Hôpital Larrey -CHU Toulouse,
Centre Léon Bérard,
Hôpital Haut-Lévêque,
Hôpital Européen Georges Pompidou (HEGP) - AP-HP,
Centre Léon Bérard,
CHU Marseille - Hôpital la Timone,
Institut de Cancérologie de l'Ouest,
CHU Marseille - Hôpital la Timone,
HUS
Funder: Institut National du Cancer Project Code: INCa-DGOS-3776
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
A randomised phase IIb trial of BEvACizumab added to Temozolomide ± IrinOtecan for children with refractory/relapsed Neuroblastoma- BEACON NEUROBLASTOMA TRIAL
assignment_turned_inProjectPartners:Université de Bordeaux, Institut Gustave Roussy, Centre Léon Bérard, Hôpitaux de Brabois Adultes-Enfants, Centre Oscar Lambret +9 partners
Université de Bordeaux,
Institut Gustave Roussy,
Centre Léon Bérard,
Hôpitaux de Brabois Adultes-Enfants,
Centre Oscar Lambret,
Délégation à la Recherche et à lInnovation - CHU Angers,
Délégation à la Recherche et à lInnovation - CHU Angers,
Hôpital des Enfants,
CHU Marseille - Hôpital la Timone,
CHU Marseille - Hôpital la Timone,
Centre Léon Bérard,
HUS,
Groupe Hospitalier Armand Trousseau - Roche Guyon,
Institut Curie
Funder: Institut National du Cancer Project Code: INCa-DGOS-7226
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu

chevron_left
1
2
3
4
5
chevron_right

CHU Marseille - Hôpital la Timone

CHU Marseille - Hôpital la Timone

79 Projects, page 1 of 16

Cancer du sein triple négatif : incidence des mutations des gênes BRCA1/2, PALB2, P53, Corrélation aux profils moléculaires et implications pronostiques Breast cancer: incidence of BRCA1/BRCA2 Mutations, correlation to moleculares profils and pronostic implications

Intérêt de la Tomographie par Emission de Positons au 18-fluorodeoxyglucose dans le dépistage du cancer chez les patients atteints de maladie veineuse thrombo-embolique idiopathique36.

Étude prospective randomisée multicentrique comparant les résultats de la greffe d’une versus deux unités de sang placentaire chez des patients âgés de moins de 35 ans atteints de leucémie aiguë en rémission.

Title of the study – First International Randomized Study in MAlignant Progressive Pheochromocytoma and Paraganglioma (PPGL)- FIRST MAPPP

A randomised phase IIb trial of BEvACizumab added to Temozolomide ± IrinOtecan for children with refractory/relapsed Neuroblastoma- BEACON NEUROBLASTOMA TRIAL

Loading